SIREN : 423295880
DMD is a French company founded 26 years ago, specialized in the sector Activités des sociétés holding. Based in SAINT-HERBLAIN (44800), this company of category ETI shows in 2024 a revenue of 7.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 948 293 € | 6 261 652 € | 4 769 884 € | 3 940 142 € | 3 272 962 € | 3 014 299 € | 2 810 041 € | 2 128 262 € | 2 250 511 € |
| Net income | 1 564 932 € | 4 295 308 € | 3 102 494 € | 644 591 € | 600 642 € | 808 453 € | 874 424 € | 687 494 € | 1 075 457 € |
| EBITDA | 192 809 € | 201 924 € | 243 571 € | 185 661 € | 72 426 € | 136 937 € | 76 991 € | -189 178 € | 1 386 950 € |
| Net margin | 19.7% | 68.6% | 65.0% | 16.4% | 18.4% | 26.8% | 31.1% | 32.3% | 47.8% |
In 2024, DMD achieves revenue of 7.9 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +17.1%. Vs 2023, growth of +27% (6.3 M€ -> 7.9 M€). After deducting consumption (0 €), gross margin stands at 7.9 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 193 k€, representing 2.4% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.6 M€, i.e. 19.7% of revenue. This profit can be retained or distributed to shareholders.
7 948 293 €
7 948 293 €
192 809 €
137 529 €
1 564 932 €
2.4%
The debt ratio (= Financial debt / Equity x 100) stands at 206%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 27.3 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 21.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
206.079%
30.164%
21.189%
27.337
26.7%
In 2024, the debt ratio of DMD (206.08) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of DMD (30.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of DMD (27.34) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 55.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1000.1x. Operating income very largely covers interest expenses: high safety margin.
55.169
1000.128
In 2024, the liquidity ratio of DMD (55.17) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of DMD (1000.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 170 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 320 days. Excellent situation: suppliers finance 150 days of the operating cycle (retail model). Overall, WCR represents 199 days of revenue, i.e. 4.4 M€ to permanently finance. Over 2016-2024, WCR increased by +49%, requiring additional financing.
4 402 083 €
170 j
320 j
0 j
199 j
Based on 54 transactions of similar company sales
in 2024,
the value of DMD is estimated at
2 327 064 €
(range 1 243 764€ - 4 809 916€).
With an EBITDA of 192 809€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare DMD with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of DMD in 2024 is 7.9 M€.
Yes, DMD generated a net profit of 1.6 M€ in 2024.
The headquarters of DMD is located in SAINT-HERBLAIN (44800), in the department Loire-Atlantique.
The tax return of DMD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
DMD operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.